These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 8712223

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Glycation of serum albumin and its role in renal protein excretion and the development of diabetic nephropathy.
    Bundschuh I, Jäckle-Meyer I, Lüneberg E, Bentzel C, Petzoldt R, Stolte H.
    Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):651-6. PubMed ID: 1493158
    [Abstract] [Full Text] [Related]

  • 3. Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with nephropathy.
    Cha T, Tahara Y, Yamato E, Yoneda H, Ikegami H, Noma Y, Shima K, Ogihara T.
    Diabetes Res Clin Pract; 1991 Jul; 12(3):149-56. PubMed ID: 1889345
    [Abstract] [Full Text] [Related]

  • 4. Glycosyl albumin and diabetic microalbuminuria: demonstration of an altered renal handling.
    Ghiggeri GM, Candiano G, Delfino G, Bianchini F, Queirolo C.
    Kidney Int; 1984 Mar; 25(3):565-70. PubMed ID: 6376909
    [Abstract] [Full Text] [Related]

  • 5. Hypertension and renal selectivity properties in diabetic microalbuminuria.
    Ghiggeri GM, Candiano G, Ginevri F, Garberi A, Acerbo S, Perfumo F, Gusmano R.
    Nephrol Dial Transplant; 1990 Mar; 5 Suppl 1():66-8. PubMed ID: 2129464
    [Abstract] [Full Text] [Related]

  • 6. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
    Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW.
    Kidney Int; 2005 Oct; 68(4):1554-61. PubMed ID: 16164632
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DPP-4 Inhibitors in Diabetic Patients with Chronic Kidney Disease and End-Stage Kidney Disease on Dialysis in Clinical Practice.
    Abe M, Okada K.
    Contrib Nephrol; 2015 Oct; 185():98-115. PubMed ID: 26023019
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice.
    Cohen MP, Hud E, Shea E, Shearman CW.
    Metabolism; 2002 Jul; 51(7):901-5. PubMed ID: 12077739
    [Abstract] [Full Text] [Related]

  • 18. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K, Shibata R, Nakayama H, Yamada K, Okuda S, Koga M.
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urinary excretion of glycated albumin in insulin-dependent diabetic patients with micro- and macroalbuminuria.
    Cavallo-Perin P, Chiambretti A, Calefato V, Tomalino M, Cecchini G, Gruden G, Pagano G.
    Clin Nephrol; 1992 Jul; 38(1):9-13. PubMed ID: 1499172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.